Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed ...
Potent Antiviral Activity in Preclinical Challenge Model: Results from a rodent challenge model showed that 100% of mice ...
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announces that the ...
ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...
Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 dataFull da ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
1don MSN
Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...
According to Benzinga Pro, Royalty Pharma's peer group average for short interest as a percentage of float is 4.00%, which ...
Zacks.com on MSN2d
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?Here is how Atyr Pharma (ATYR) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...
No. 4 / 2025Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback